Cyient DLM Board of Directors

Get the latest insights into the leadership at Cyient DLM. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Krishna Bodanapu Non Executive Chairman
Mr. Rajendra Velagapudi Managing Director
Mr. B V R Mohan Reddy Non Executive Director
Ms. Vanitha Datla Independent Director
Mr. Jehangir Ardeshir Independent Director
Mr. Muralidhar Yadama Independent Director
Dr. Ajay Kumar Independent Director
Mr. Madan Pillutla Independent Director

Cyient DLM Share price

CYIENTDLM

430.15

9.70 (-2.21%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:31 IST
BUYSELL
Today's High

443.90

Today's Low

428.10

52 Week Low

378.60

52 Week High

750.80

The current prices are delayed, login to your account for live prices

Cyient DLM FAQs

The board at Cyient DLM consists of experienced professionals, including Mr. Krishna Bodanapu , Mr. Rajendra Velagapudi , and others, overseeing the company’s strategic and corporate governance.

Directors at Cyient DLM are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Krishna Bodanapu is the current chairman at Cyient DLM.

Executive directors at Cyient DLM are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Cyient DLM adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Cyient DLM, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.